Intradermal, Fractional Dose of HPV Vaccines:
Public ClinicalTrials.gov record NCT04235257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.
Study identification
- NCT ID
- NCT04235257
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 27 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2020
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2026
- Last update posted
- May 4, 2026
2020 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Washington Virology Research Clinic | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated HPV Infection trials
Other public records listing HPV Infection. Sorted by last update posted; newest first. Not a recommendation.
- NCT06959563: Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV Active, not recruiting
- NCT05291871: Immunogenicity of Fractional Dose of the HPV Vaccines Active, not recruiting
- NCT04206813: An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen Active, not recruiting
- NCT07453459: Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening Recruiting
- NCT06210854: Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ Not yet recruiting
- NCT07281599: Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04235257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04235257 live on ClinicalTrials.gov.